ANIMALCARE GROUP PLC

Notice of Dividend Amount • Sep 25, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9215B

Animalcare Group PLC

25 September 2018

25 September 2018

Animalcare Group plc

("Animalcare", the "Company" or the "Group")

Dividend declaration for the six months ended 30 June 2018

Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, is pleased to announce that it will pay an interim dividend of 2.0 pence per ordinary share on 23rd November 2018 to shareholders whose names are on the Register of Members at close of business on 26th October 2018. The ordinary shares will become ex-dividend on 25th October 2018.

For further information, please contact:

Animalcare Group plc	Tel: 01904 487 687
Chris Cardon, Chief Executive Officer
Panmure Gordon (Nominated Adviser & Broker)	Tel: 020 7886 2500
Corporate Finance
Freddy Crossley / Emma Earl
Corporate Broking
James Stearns
Consilium Strategic Communications	animalcare@consilium-comms.com
Amber Fennell / Chris Welsh / Hendrik Thys

About Animalcare (www.animalcaregroup.co.uk)

Animalcare Group plc is a UK AIM listed veterinary sales, marketing and product development company resulting from the merger of Animalcare and Ecuphar NV.

Post-merger Animalcare is a pan-European animal health company, with a broad geographic footprint. The Company now has direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany) and exports to approximately 50 markets worldwide.

The enlarged Company has nearly 100 sales representatives and 28 agents operating across Europe and owns 50 licensed drugs, eight vaccines and over 100 care and nutraceutical products.

Animalcare invests in developing its own pharmaceutical products, seeks distribution partnerships and product acquisitions.

For more information see Animalcare Ltd (www.animalcare.co.uk) and Ecuphar NV (www.ecuphar.com).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DIVLAMFTMBJTBAP